257 related articles for article (PubMed ID: 30864758)
1. Serological Detection of Ebola Virus Exposures in Native Non-human Primates of Southern Nigeria.
Ogunro BN; Olugasa BO; Verschoor EJ; Olarinmoye AO; Theyse I; Niphuis H
J Epidemiol Glob Health; 2018 Dec; 8(3-4):162-170. PubMed ID: 30864758
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
Front Immunol; 2021; 12():703986. PubMed ID: 34484200
[TBL] [Abstract][Full Text] [Related]
3. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
4. Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.
Babirye P; Musubika C; Kirimunda S; Downing R; Lutwama JJ; Mbidde EK; Weyer J; Paweska JT; Joloba ML; Wayengera M
BMC Infect Dis; 2018 Oct; 18(1):498. PubMed ID: 30285648
[TBL] [Abstract][Full Text] [Related]
5. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
6. Serological Evidence of Filovirus Infection in Nonhuman Primates in Zambia.
Changula K; Simulundu E; Lombe BP; Nakayama E; Miyamoto H; Takahashi Y; Sawa H; Simukonda C; Hang'ombe BM; Takada A
Viruses; 2021 Jun; 13(7):. PubMed ID: 34209295
[TBL] [Abstract][Full Text] [Related]
7. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
[TBL] [Abstract][Full Text] [Related]
8. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
[TBL] [Abstract][Full Text] [Related]
9. Serological evidence of Ebola virus infection in Indonesian orangutans.
Nidom CA; Nakayama E; Nidom RV; Alamudi MY; Daulay S; Dharmayanti IN; Dachlan YP; Amin M; Igarashi M; Miyamoto H; Yoshida R; Takada A
PLoS One; 2012; 7(7):e40740. PubMed ID: 22815803
[TBL] [Abstract][Full Text] [Related]
10. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
Geisbert TW; Strong JE; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223
[TBL] [Abstract][Full Text] [Related]
11. Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors.
Bramble MS; Hoff N; Gilchuk P; Mukadi P; Lu K; Doshi RH; Steffen I; Nicholson BP; Lipson A; Vashist N; Sinai C; Spencer D; Olinger G; Wemakoy EO; Illunga BK; Pettitt J; Logue J; Marchand J; Varughese J; Bennett RS; Jahrling P; Cavet G; Serafini T; Ollmann Saphire E; Vilain E; Muyembe-Tamfum JJ; Hensely LE; Simmons G; Crowe JE; Rimoin AW
J Infect Dis; 2018 Nov; 218(12):1929-1936. PubMed ID: 30107445
[TBL] [Abstract][Full Text] [Related]
12. Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein.
Changula K; Yoshida R; Noyori O; Marzi A; Miyamoto H; Ishijima M; Yokoyama A; Kajihara M; Feldmann H; Mweene AS; Takada A
Virus Res; 2013 Sep; 176(1-2):83-90. PubMed ID: 23702199
[TBL] [Abstract][Full Text] [Related]
13. Development, validation and clinical evaluation of a broad-range pan-filovirus RT-qPCR.
Jääskeläinen AJ; Sironen T; Diagne CT; Diagne MM; Faye M; Faye O; Faye O; Hewson R; Mölsä M; Weidmann MW; Watson R; Sall AA; Vapalahti O
J Clin Virol; 2019 May; 114():26-31. PubMed ID: 30904708
[TBL] [Abstract][Full Text] [Related]
14. Serological evidence of exposure to ebolaviruses in domestic pigs from Guinea.
Fischer K; Camara A; Troupin C; Fehling SK; Strecker T; Groschup MH; Tordo N; Diederich S
Transbound Emerg Dis; 2020 Mar; 67(2):724-732. PubMed ID: 31627257
[TBL] [Abstract][Full Text] [Related]
15. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
Stock I
Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
[TBL] [Abstract][Full Text] [Related]
16. Production and Purification of Filovirus Glycoproteins.
Noonan-Shueh M; Aman MJ; Kailasan S
Methods Mol Biol; 2024; 2762():17-25. PubMed ID: 38315357
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
Pessi A; Bixler SL; Soloveva V; Radoshitzky S; Retterer C; Kenny T; Zamani R; Gomba G; Gharabeih D; Wells J; Wetzel KS; Warren TK; Donnelly G; Van Tongeren SA; Steffens J; Duplantier AJ; Kane CD; Vicat P; Couturier V; Kester KE; Shiver J; Carter K; Bavari S
Antiviral Res; 2019 Nov; 171():104592. PubMed ID: 31473342
[TBL] [Abstract][Full Text] [Related]
18. Identification and Characterization of Defective Viral Genomes in Ebola Virus-Infected Rhesus Macaques.
Johnson RI; Boczkowska B; Alfson K; Weary T; Menzie H; Delgado J; Rodriguez G; Carrion R; Griffiths A
J Virol; 2021 Aug; 95(17):e0071421. PubMed ID: 34160256
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins.
Nyakatura EK; Zak SE; Wec AZ; Hofmann D; Shulenin S; Bakken RR; Aman MJ; Chandran K; Dye JM; Lai JR
J Biol Chem; 2018 Apr; 293(16):6201-6211. PubMed ID: 29500195
[TBL] [Abstract][Full Text] [Related]
20. Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.
Bratcher A; Hoff NA; Doshi RH; Gadoth A; Halbrook M; Mukadi P; Musene K; Ilunga-Kebela B; Spencer D; Bramble MS; McIlwan D; Kelly JD; Mukadi D; Kingebeni PM; Ahuka S; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Rimoin AW
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009566. PubMed ID: 34383755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
